Deep Track Capital, LP Century Therapeutics, Inc. Transaction History

Deep Track Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.0 - $3.23 $959,768 - $1.55 Million	-479,884 Reduced 46.91%	543,008 $1.09 Million
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $1.11 Million - $1.67 Million	327,047 Added 47.0%	1,022,892 $3.55 Million
Q4 2022 Feb 14, 2023	SELL	$4.84 - $11.58 $1.11 Million - $2.65 Million	-228,796 Reduced 24.74%	695,845 $3.57 Million
Q2 2022 Aug 12, 2022	SELL	$7.96 - $12.43 $14,550 - $22,722	-1,828 Reduced 0.2%	924,641 $7.77 Million
Q1 2022 May 16, 2022	BUY	$11.62 - $15.92 $7.86 Million - $10.8 Million	676,469 Added 270.59%	926,469 $11.7 Million
Q4 2021 Feb 14, 2022	BUY	$13.93 - $23.62 $3.48 Million - $5.91 Million	250,000 New	250,000 $3.97 Million

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $71.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.